Pattern of phospholipids and Surfactant Protein A in Particles in Exhaled Air (PExA)

A. Olin (Gothenburg, Sweden)

Source: International Congress 2017 – Techniques in biomarker selection
Session: Techniques in biomarker selection
Session type: Oral Presentation
Number: 2938
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Olin (Gothenburg, Sweden). Pattern of phospholipids and Surfactant Protein A in Particles in Exhaled Air (PExA). 2938

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surfactant Protein A in Particles in Exhaled Air and serum
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Indoor Air Freshener Extract Increases Pneumococcal Adhesion to Airway Cells
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019

Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017



Exhaled surfactant protein A and albumin in a healthy Swedish population
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide
Source: Guideline 2005
Year: 2005

Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Inhibition of Mast Cell Degranulation by Surfactant Protein D
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Nebulizer Location and spontaneous breathing on Aerosol Delivery during Airway Pressure Release Ventilation in Adult Lung Model
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018

Iron Oxide and Titanium Dioxide Nanoparticles Reduce Alveolar Epithelial Cell Stiffening and Contraction Forces
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021

Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017



Combining Inhalation by A Breath Actuated Nebuliser (BAN) With Exhalation Through An Oscillating Positive Expiratory Pressure Device (OPEP) Offers The Potential For Optimal Combined Therapy
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Significant Discrimination of unknown bacterial Infections by Analysis of VOCs in exhaled Air or Headspace  from Infected Regions
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Effects of Intrauterine Exposure to Concentrated Ambient Particles on Mice Offspring Sensitized with House Dust Mite
Source: International Congress 2017 – Air pollution
Year: 2017